Saudi Arabia, UK sign agreement to accelerate access to innovative medical treatments
LONDON — The Saudi Food and Drug Authority (SFDA) signed a memorandum of understanding (MoU) with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to advance the evaluation of innovative treatments and facilitate timely patient access to them. The agreement was signed by SFDA Chief Executive Officer Dr. Hisham bin Saad Al-Jadhey and MHRA Chief Executive Lawrence Tallon on the…
We haven't written up this one. Saudi Gazette has the full story — the link below goes straight to it.